ESTEVE PHARMACEUTICALS SA
ItalyAll drugs from this manufacturer
-
The drug is used as a diagnostic test to evaluate pituitary function (to identify insufficient ACTH levels or to diagnose a specific type of Cushing's syndrome) and for the treatment of the signs and symptoms of endogenous Cushing's syndrome, with the aim of lowering elevated cortisol levels.
Dosage form: capsules, soft gelatin
Active substance Dosage metirapone - ATC: V04CD01
-
It is used to treat children and adolescents (from 2 to 18 years old) who present with very short stature for their age due to primary IGF-1 deficiency, a condition in which the body does not produce enough of this substance.
Dosage form: solution for injection
Active substance Dosage mecasermine - ATC: H01AC03
-
It is used to treat endogenous Cushing's syndrome in adults and adolescents over 12 years of age. This condition is caused by an excess of cortisol produced by the adrenal glands; the drug helps to block the production of this hormone and improve symptoms.
Dosage form: tablets
Active substance Dosage ketoconazole - ATC: H02CA03
-
It is an anticancer drug used to treat the symptoms of advanced malignant tumors of the adrenal glands that cannot be operated on, have spread (metastatic), or have recurred (recurrent).
Dosage form: tablets
Active substance Dosage mitotane - ATC: L01XX23
-
It is used for the treatment of osteosarcoma (a type of bone cancer) in children, adolescents, and young adults between 2 and 30 years of age. It is administered after surgery to remove the tumor and together with chemotherapy to eliminate remaining cancer cells and reduce the risk of recurrence.
Dosage form: powder for preparation of injectable suspension
Active substance Dosage mifamurtide - ATC: L03AX15